<DOC>
	<DOCNO>NCT02068690</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics BI 425809 follow single rise dos BI 425809 healthy male volunteer ; To explore dose proportionality BI 425809 oral drinking solution ; To investigate relative bioavailability BI 425809 oral drink solution fast compare BI 425809 tablet fast tablet fed</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Single Doses BI 425809</brief_title>
	<detailed_description />
	<criteria>Inclusion criterion : Healthy male subject Age 18 45 year ( incl . ) Body mass index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) Subject must able understand comply study requirement Exclusion criterion : Any find medical examination ( include blood pressure ( BP ) , pulse rate ( PR ) electrocardiogram ( ECG ) ) deviate normal judge clinically relevant investigator Repeated measurement systolic blood pressure &lt; 90 &gt; 140 mmHg , diastolic blood pressure &lt; 50 &gt; 90 mmHg , pulse rate &lt; 50 &gt; 90 Any laboratory value outside reference range investigator considers clinical relevance Any evidence concomitant disease judge clinically relevant investigator Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract could interfere kinetics study drug ( ) Diseases central nervous system ( epilepsy ) , neurological disorder psychiatric disorder</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>